The artificial sweetener that's been a staple in American households for decades is now facing fresh scrutiny, as emerging ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

The human cost Additional studies highlighted ... they are a trusted source for US patients seeking cost-effective insulin solutions.

Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). If you accidentally take too much or your blood sugar is low for ...

Many Indians laid low by disease turned to biohacking. Others are healthy but want to live longer. Aiding them in the efforts ...

as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first ...